Network Bio Q1 2023 Investor Update - by network.bio
Network Bio is a horizontal platform generating multi-Omic data across indications — we partner with health systems to build a family of disease-specific tissue biobanks linked to continuous EHR
Network Bio Q1 2023 Investor Update Network Bio is a horizontal platform generating multi-Omic data across indications — we partner with health systems to build a family of disease-specific tissue biobanks linked to continuous EHR network.bio Apr 12, 2023 Share I. Network’s 2023 objective Enter legal relationships with sufficient health systems to collectively provide us a top-of-the-funnel 4,000,000 unique patient encounters per year. This enables us to run studies of choice across multiple indications simultaneously. Raise a priced-round wherein we will pilot this concept with our Network of
Explore this link on the map →saved by
related reading
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- Gap Mapgap-map.org
- Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershbergcenturyofbio.com
- The Age of Tech x Bio: The 'Industrial Bio Complex' | Andreessen Horowitza16z.com
- Paving the way for agents in biology \ Anthropicanthropic.com
- Mediummariellesophiagross.medium.com
- Biochemical Network Analysischemnet.univie.ac.at
- Tech vs Biotech - Celine Haliouacelinehh.com
- Reasons to be pessimistic (and optimistic) on the future of biosecurityowlposting.com
- Quantitative biology – a perspective for the life sciences' way into the future - Business Chemistrybusinesschemistry.org
- Synbio25 - A man thinks about building biologysynbio25.com
- Book Review: Design Principles of Biological Circuits — LessWronglesswrong.com